Skip to main content
Certara, Inc. (CERT)
NASDAQ: CERT · Real-Time Price · USD
10.71
+0.16 (1.52%)
Dec 20, 2024, 4:00 PM EST - Market closed

Certara Revenue

Certara had revenue of $94.82M in the quarter ending September 30, 2024, with 10.80% growth. This brings the company's revenue in the last twelve months to $372.80M, up 5.62% year-over-year. In the year 2023, Certara had annual revenue of $354.34M with 5.57% growth.

Revenue (ttm)
$372.80M
Revenue Growth
+5.62%
P/S Ratio
4.60
Revenue / Employee
$268,006
Employees
1,391
Market Cap
1.72B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023354.34M18.69M5.57%
Dec 31, 2022335.64M49.54M17.32%
Dec 31, 2021286.10M42.57M17.48%
Dec 31, 2020243.53M35.02M16.79%
Dec 31, 2019208.51M44.79M27.36%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Astrana Health 1.72B
Integra LifeSciences Holdings 1.56B
GoodRx Holdings 790.39M
MannKind 267.20M
Dynavax Technologies 260.81M
Xencor 85.16M
Recursion Pharmaceuticals 65.18M
Celldex Therapeutics 9.98M
Revenue Rankings

CERT News

More News